40 related articles for article (PubMed ID: 10229992)
1. Rhinitis Control and Medication Use in a Real-World Sample of Patients With Persistent Rhinitis or Rhinosinusitis: A Community Pharmacy Study.
Scheire S; Germonpré S; Mehuys E; Van Tongelen I; De Sutter A; Steurbaut S; Van Hees T; Demarche S; Lahousse L; Gevaert P; Boussery K
J Allergy Clin Immunol Pract; 2024 Jul; 12(7):1865-1876.e6. PubMed ID: 38677586
[TBL] [Abstract][Full Text] [Related]
2. Cohort profile: prescriptions dispensed in the community linked to the national cancer registry in England.
Henson KE; Brock R; Shand B; Coupland VH; Elliss-Brookes L; Lyratzopoulos G; Godfrey P; Haigh A; Hunter K; McCabe MG; Mitchell G; Monckton N; Robson R; Round T; Wong K; Rashbass J
BMJ Open; 2018 Jul; 8(7):e020980. PubMed ID: 29991628
[TBL] [Abstract][Full Text] [Related]
3. Association of over-the-counter pharmaceutical sales with influenza-like-illnesses to patient volume in an urgent care setting.
Liu TY; Sanders JL; Tsui FC; Espino JU; Dato VM; Suyama J
PLoS One; 2013; 8(3):e59273. PubMed ID: 23555647
[TBL] [Abstract][Full Text] [Related]
4. Pharmacists' Attitudes Towards Long-Term Use of Nasal Decongestants: A Cross-Sectional Study.
Mokhatrish MM; Almatrafi SD; Aldrees TM; Aldriweesh TA; AlGhamdi FM; Al-Dosary AS; Alhumaydani NK; Aldakkan OZ; Alrudian N; Ali AH
J Multidiscip Healthc; 2024; 17():1079-1090. PubMed ID: 38505655
[TBL] [Abstract][Full Text] [Related]
5. The spatiotemporal association of non-prescription retail sales with cases during the 2009 influenza pandemic in Great Britain.
Todd S; Diggle PJ; White PJ; Fearne A; Read JM
BMJ Open; 2014 Apr; 4(4):e004869. PubMed ID: 24780494
[TBL] [Abstract][Full Text] [Related]
6. Hemorrhagic stroke caused by xylometazoline poisoning.
Banaś BP; Brzeźniakiewicz-Janus K; Majdanik S; Parafiniuk M; Łużny S; Stachowicz A; Janus T
J Forensic Sci; 2024 Jan; 69(1):359-364. PubMed ID: 37919943
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic therapeutic assistance pathway (PDTA) of type 2 chronic rhinosinusitis.
Canevari FR; Giorli A; Monti G; Biagini C; Bagnasco D; Cavaliere C; Pipolo C; De Corso E; Gelardi M; Gramellini G; Ioppi A; La Mantia I; Malvezzi L; Bignami M; Dehgani-Mobaraki P; Seccia V; Maggiore G; Macchi A
Front Allergy; 2023; 4():1237131. PubMed ID: 37841050
[TBL] [Abstract][Full Text] [Related]
8. Use of non-steroidal anti-inflammatory drugs in US adults: changes over time and by demographic.
Davis JS; Lee HY; Kim J; Advani SM; Peng HL; Banfield E; Hawk ET; Chang S; Frazier-Wood AC
Open Heart; 2017; 4(1):e000550. PubMed ID: 28674622
[TBL] [Abstract][Full Text] [Related]
9. How removing prescription drugs from reimbursement lists increases the pharmaceutical expenditures for alternatives.
Gür Ali O; Topaler B
Eur J Health Econ; 2011 Dec; 12(6):553-62. PubMed ID: 20717700
[TBL] [Abstract][Full Text] [Related]
10. Switching of prescription drugs to over-the-counter status: is it a good thing for the elderly?
Francis SA; Barnett N; Denham M
Drugs Aging; 2005; 22(5):361-70. PubMed ID: 15903349
[TBL] [Abstract][Full Text] [Related]
11. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of H2-receptor antagonists.
Andrade SE; Gurwitz JH; Fish LS
Med Care; 1999 Apr; 37(4):424-30. PubMed ID: 10213023
[TBL] [Abstract][Full Text] [Related]
12. The influence of Rx-to-OTC changes on drug sales. Experiences from Sweden 1980-1994.
Carlsten A; Wennberg M; Bergendal L
J Clin Pharm Ther; 1996 Dec; 21(6):423-30. PubMed ID: 9201570
[TBL] [Abstract][Full Text] [Related]
13. [Decongestants in treatment of nasal obstruction].
Bogacka E
Otolaryngol Pol; 1999; 53(3):347-52. PubMed ID: 10481510
[TBL] [Abstract][Full Text] [Related]
14. Topical nasal decongestants.
Engle JP
Am Pharm; 1992 May; NS32(5):33-7. PubMed ID: 1375430
[No Abstract] [Full Text] [Related]
15. The impact of over-the-counter availability of nasal sprays on sales, prescribing, and physician visits.
Lundberg L; Isacson D
Scand J Prim Health Care; 1999 Mar; 17(1):41-5. PubMed ID: 10229992
[TBL] [Abstract][Full Text] [Related]
16. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products.
Gurwitz JH; McLaughlin TJ; Fish LS
Health Serv Res; 1995 Dec; 30(5):672-85. PubMed ID: 8537226
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
